"Amici feel a responsibility to inform this Court about the medical community’s consensus regarding best practices when treating transgender individuals for gender dysphoria and providing gender-affirming care. Amici, as leading healthcare providers both within the State of Iowa and beyond, are in a unique position to inform the Court about the proper treatments for people experiencing gender dysphoria, the negative health outcomes when gender dysphoria is left untreated, and other health concerns that could arise from lack of coverage by Medicaid plans for the medically appropriate and evidence-based treatments for gender dysphoria. Amici believe that this information will assist the Court by presenting a complete and accurate description of the medical conditions and treatments at issue in the pending case."
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.